A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

Treatment Patterns and Outcomes in Unresectable or Metastatic Renal Cell Carcinoma (mRCC) Patients in Japan

A medical review chart study in Japan to describe the treatment patterns and outcomes of patients with kidney cancer that is unable to be removed by surgery or that has spread. The clinical data is to be abstracted using electronic data capture (eDC) from patient medical records in Japan.

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

• Adults 20 years and older at the time of initial diagnosis of mRCC
• Alive or deceased as of the date of data collection
• Diagnosis of mRCC between 01-Jan-2012 and 31-Aug-2015

Exclusion Criteria:

• Previously and/or currently enrolled in RCC clinical trials
• Patients have primary cancer other than renal cell cancer